We proposed that the formation of the C1q-ApoE complex in atherosclerosis and Alzheimer’s Disease may indicate a universal common self-regulating mechanism of CCC-dependent inflammation in a wide range of inflammation-related diseases to control CCC activity ́s via a feedback inhibition of its initiating protein (1). The gene discussed is APOE; the disease is atherosclerosis.